GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human JARID1B in complex with 2-oxoglutarate.

Analyse Crystal structure of human JARID1B in complex with 2-oxoglutarate. in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5FUP
Type
protein
Length
454 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lysine-specific demethylase 5B
EC
1.14.11.-
UniProt
Q9UGL1
Ligands
AKG, ZN, MN, CL
Pockets
6 · best druggability 0.76

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALysine-specific demethylase 5B (EC 1.14.11.-)protein45438% helix, 20% strandQ9UGL1

Ligands and binding sites

  • AKG · 2-oxoglutaric acid · ligand · chains A
  • ZN · Zinc ion · metal · 2 copies · chains A
  • MN · Manganese (II) ion · metal · 2 copies · chains A
  • CL · Chloride ion · ion · chains A
  • EDO · 1,2-ethanediol · additive · 9 copies · chains A
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13890.760.8639MN, AKG, EDO
22770.750.8831EPE
31900.740.9123EDO
41170.420.7619empty
5610.330.7616EDO

Compared structures

  • 5FUP · Crystal structure of human JARID1B in complex with 2-oxoglutarate. · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UGL1 · AlphaFold monomer V2.0 prediction for lysine-specific demethylase 5B (Q9UGL1) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.